Berta Díaz‐Feijoó

ORCID: 0000-0002-6451-1817
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Uterine Myomas and Treatments
  • Cervical Cancer and HPV Research
  • Endometriosis Research and Treatment
  • Cancer survivorship and care
  • Intraperitoneal and Appendiceal Malignancies
  • Sarcoma Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Reconstructive Surgery and Microvascular Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal and Anal Carcinomas
  • Cardiac, Anesthesia and Surgical Outcomes
  • Ovarian function and disorders
  • Gynecological conditions and treatments
  • Management of metastatic bone disease
  • Cancer Risks and Factors
  • Organ and Tissue Transplantation Research
  • Reproductive Biology and Fertility
  • Trauma and Emergency Care Studies
  • Minimally Invasive Surgical Techniques
  • Cancer Genomics and Diagnostics
  • Renal cell carcinoma treatment
  • Cancer Diagnosis and Treatment
  • Colorectal Cancer Surgical Treatments

Hospital Clínic de Barcelona
2019-2025

Universitat de Barcelona
2019-2025

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2019-2025

Universitat Autònoma de Barcelona
2013-2024

Fundació Clínic per a la Recerca Biomèdica
2024

Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
2024

Gynecologic Oncology Group
2020-2022

Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
2020-2022

Departament de Salut
2022

Vall d'Hebron Institut de Recerca
2016-2021

The aim of this study was to investigate the possible role STAT4 gene in genetic predisposition systemic sclerosis (SSc) susceptibility or clinical phenotype. A total 1317 SSc patients [896 with limited cutaneous (lcSSc) and 421 diffuse (dcSSc)] 3113 healthy controls, from an initial case–control set Spanish Caucasian ancestry five independent cohorts European (The Netherlands, Germany, Sweden, Italy USA), were included study. rs7574865 polymorphism selected as marker. We observed that T...

10.1093/hmg/ddp119 article EN Human Molecular Genetics 2009-03-13

Treatment for advanced ovarian cancer (AOC) comprises cytoreductive surgery combined with chemotherapy. Multimodal prehabilitation programmes before have demonstrated efficacy in postoperative outcomes non-gynaecological surgeries. However, the viability and effects of these on patients AOC are unknown. We aimed to evaluate feasibility impact a multimodal programme undergoing surgery.This single-centre, before-and-after intervention pilot study included 34 two cohorts: cohort prospectively...

10.3390/cancers14071635 article EN Cancers 2022-03-23

The main aim is to compare oncological outcomes and patterns of recurrence patients with early-stage endometrioid endometrial cancer according lymphovascular space invasion (LVSI) status. secondary objective determine preoperative predictors LVSI. We performed a multicenter retrospective cohort study. A total 3546 women diagnosed postoperative (FIGO I-II, 2009) were included. Co-primary endpoints disease-free survival (DFS), overall (OS), pattern recurrence. Cox proportional hazard models...

10.3390/cancers15092612 article EN Cancers 2023-05-04

Background Positron emission tomography/computed tomography (PET/CT) fails to detect approximately 25% of aortic lymph node metastasis in patients with PET/CT stage IIIC1 cervical cancer. Surgical staging could lead treatment modification and improved para-aortic distant control. Primary Objective(s) To demonstrate if chemoradiation tailored external beam radiation field based on surgical pathologic examination the is associated 3-year disease-free survival compared staged only. Study...

10.1136/ijgc-2022-004223 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2023-01-30

Patients with cervical cancer treatment experience an impairment of sexual function and quality life. This issue is usually underreported undertreated, evidence-based interventions are lacking. Prevention dysfunction a crucial pillar in improving the life these patients. The primary objective this trial to evaluate impact multimodal intervention, encompassing prevention vaginal patient education, on survivors utilizing patient-reported outcome measurements. Multi-institutional, randomized...

10.3802/jgo.2025.36.e56 article EN cc-by-nc Journal of Gynecologic Oncology 2025-01-01
Coming Soon ...